查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2080348

生物材料市場：按類型、產品形式、應用和最終用戶分類－2026-2032年全球市場預測

Biomaterials Market by Type, Product Form, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物材料市場將成長至 1,313 億美元，複合年成長率為 12.92%。

主要市場統計數據
基準年 2025 560.7億美元
預計年份：2026年 630.2億美元
預測年份：2032年 1313億美元
複合年成長率 (%) 12.92%

生物材料市場簡介

生物材料市場在現代醫學中佔據著越來越重要的地位，涵蓋了用於植入、創傷護理、藥物傳輸、組織工程、牙科產品和先進外科器械的生物相容性金屬、陶瓷、聚合物、水凝膠、複合材料和生物可吸收材料。

生物材料領域的變革性變化

生物材料領域正從惰性、替代性材料轉向能夠與生物系統主動相互作用的功能性平台。儘管整形外科和牙科領域仍然大量依賴鈦合金、不銹鋼、鈷鉻合金、氧化鋁和氧化鋯，但創新最快的領域是生物活性陶瓷、可生物分解聚合物、抗菌塗層、水凝膠、細胞外基質材料和人工組織支架。

人工智慧的累積影響

人工智慧正成為生物材料發現、表徵和製造整個過程中一股切實的驅動力。透過使用機器學習模型，可以比傳統的試驗試驗更快地篩檢聚合物化學結構、預測力學性能、評估分解曲線並識別結構-性能關係。

生物材料領域的關鍵區域見解

亞太地區正崛起為高成長的生物材料中心，這得益於中國、印度、日本、韓國和澳洲龐大的病患群體、不斷擴張的醫療設備製造業以及支持本土創新的政策。需求量最大的領域包括整形外科植入、牙科生物材料、心血管醫療設備、創傷護理、眼科和再生醫學。日本和韓國人口老化，以及中國和印度慢性病負擔日益加重，都推動了長期的臨床需求。

全球生物材料市場關鍵群體分析

隨著醫療旅遊、醫院投資和本地醫療設備組裝的擴張，東協市場在新加坡、泰國、馬來西亞、印尼、越南和菲律賓的重要性日益凸顯。儘管該地區在牙科產品、傷口敷料、外科耗材和具有成本競爭力的聚合物醫療設備佔據優勢地位，但監管協調、高效的產品註冊和臨床檢驗仍然是關鍵的差異化因素。

各國在生物材料方面的關鍵見解

美國憑藉強大的醫療技術生態系統、聯邦政府資助的生物醫學研究、與美國食品藥物管理局（FDA）的合作以及在整形外科、循環系統、創傷護理、牙科、眼科和藥物輸送等領域的產品開發，引領著生物材料創新。加拿大受益於再生醫學研究、生物材料科學和醫院創新，而墨西哥則在醫療設備製造、近岸外包和跨境供應鏈整合方面不斷加強自身作用。

生物材料產業領導者使用的實用建議

產業領導者應優先考慮能夠解決特定臨床挑戰的生物材料平台，例如肌肉骨骼疾病、糖尿病相關傷口、心血管疾病、牙齒修復、眼科疾病和老齡化相關性組織退化。產品組合決策應基於可衡量的結果，包括降低感染率、加速治療、改善骨整合、延長植入壽命、減輕發炎和減少再次手術。

調查方法

本執行摘要採用系統性的二手研究途徑，並遵循市場情報最佳實踐編寫而成。研究資料包括公共衛生資料集、監管指南、同儕審查文獻、醫療設備標準、臨床應用趨勢、生產指標以及與生物材料需求相關的宏觀經濟因素。

結論

生物材料正從被動的結構組件轉向智慧、生物活性和應用特定的平台轉變，從而改善患者的治療效果。人口老化、慢性病盛行率上升、外科手術技術的創新、創傷治療的需求以及對更安全、更持久的醫療技術的需求，都是推動生物材料發展的主要因素。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生物材料市場：依類型分類

  • 陶瓷製品
    • 氧化鋁
    • 生物玻璃
    • 羥磷石灰
    • 氧化鋯
  • 金屬
  • 合成聚合物
    • 聚己內酯（PCL）
    • 聚乙醇酸（PGA）
    • 聚乳酸（PLA）
    • 聚乳酸-羥基乙酸共聚物（PLGA）
    • 聚乙烯（PE）
    • 聚丙烯（PP）
    • 聚氨酯（PU）
    • 聚乙烯醇（PVA）

第8章：生物材料市場：依產品形式分類

  • 粉末/顆粒
  • 纖維和網狀物
  • 電影
  • 發泡體
  • 塗層

第9章：生物材料市場：依應用領域分類

  • 心血管系統
    • 導管導引線
    • 植入式心臟去心房顫動
    • 心律調節器
    • 感應器
    • 支架
    • 血管移植
  • 牙科
    • 骨移植材料和骨替代材料
    • 牙科植體
    • 牙膜
    • 組織再生材料
  • 眼科
  • 整形外科
    • 生物可吸收組織固定產品
    • 用於關節重建的生物材料
    • 骨科生技藥品
    • 用於脊椎的生物材料
    • 關節內粘稠補充療法
  • 泌尿器官系統
  • 傷口護理
    • 防沾黏材料
    • 骨折治療裝置
    • 內組織密封膠
    • 皮膚替代材料
    • 外科止血劑

第10章：生物材料市場：依最終用戶分類

  • 生技公司
  • 醫院
  • 研究所
  • 專科診所

第11章：生物材料市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：生物材料市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：生物材料市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Aroa Biosurgery Limited
  • BASF SE
  • Berkeley Advanced Biomaterials Inc.
  • Bezwada Biomedical, LLC
  • Carpenter Technology Corporation
  • Celanese Corporation
  • CoorsTek, Inc.
  • Corbion NV
  • Covestro AG
  • Dentsply Sirona Inc.
  • DSM-Firmenich AG
  • Evonik Industries AG
  • Exactech, Inc.
  • Heraeus Holding GmbH
  • Integra LifeSciences Corporation
  • Invibio Limited
  • Modern Meadow, Inc.
  • MycoWorks, Inc.
  • Noble Biomaterials, Inc.
  • Stryker Corporation
  • TissueForm, Inc.
  • WL Gore & Associates, Inc.
Product Code: MRR-434CCDA04CCF

The Biomaterials Market is projected to grow by USD 131.30 billion at a CAGR of 12.92% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 56.07 billion
Estimated Year [2026] USD 63.02 billion
Forecast Year [2032] USD 131.30 billion
CAGR (%) 12.92%

Biomaterials Market Introduction

The biomaterials market is increasingly central to modern healthcare, spanning biocompatible metals, ceramics, polymers, hydrogels, composites, and bioresorbable materials used in implants, wound care, drug delivery, tissue engineering, dental products, and advanced surgical devices.

Growth is also shaped by aging populations, higher surgical volumes, stronger reimbursement scrutiny, and stricter biocompatibility expectations under frameworks such as ISO 10993, U.S. FDA guidance, and the European Union Medical Device Regulation. As a result, industry leaders are prioritizing materials that demonstrate safety, durability, manufacturability, sterilization compatibility, and measurable patient outcomes.

Transformative Shifts in the Biomaterials Landscape

The biomaterials landscape is shifting from inert, replacement-focused materials toward functional platforms that actively interact with biological systems. Orthopedic and dental applications still rely heavily on titanium alloys, stainless steel, cobalt-chromium, alumina, and zirconia, but the fastest innovation is occurring in bioactive ceramics, degradable polymers, antimicrobial coatings, hydrogels, extracellular matrix materials, and engineered tissue scaffolds.

Regulatory expectations are transforming product development. The EU MDR has raised clinical evidence requirements, while the FDA continues to emphasize risk-based biocompatibility assessment, chemical characterization, and device-specific performance testing. This is pushing manufacturers to invest earlier in toxicology, extractables and leachables, sterility assurance, usability, and long-term post-market surveillance.

Supply chain resilience is another defining shift. Medical-grade polymers, specialty ceramics, rare metals, collagen sources, and validated contract manufacturing capacity are now strategic assets. Companies that can qualify alternative suppliers, document traceability, maintain consistent material specifications, and reduce single-source exposure are better positioned to protect quality, support approvals, and sustain clinical supply.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator across biomaterials discovery, characterization, and manufacturing. Machine learning models can screen polymer chemistries, predict mechanical properties, evaluate degradation profiles, and identify structure-property relationships faster than traditional trial-and-error experimentation.

AI is especially valuable where biomaterials require simultaneous optimization across competing factors, including tensile strength, elasticity, porosity, bioactivity, cytocompatibility, hemocompatibility, sterilization tolerance, and cost. Digital image analysis is improving histology interpretation, surface morphology evaluation, contamination detection, and defect identification in additive manufacturing and coating processes.

The cumulative impact is a shorter development cycle, stronger design controls, and more evidence-rich regulatory submissions. However, AI adoption must be governed by validated datasets, explainable models, cybersecurity controls, audit trails, and documented change management, particularly when algorithmic outputs influence device design, process validation, or quality release decisions.

Key Regional Insights for Biomaterials

Asia-Pacific is emerging as a high-growth biomaterials hub, supported by large patient populations, expanding medical device manufacturing, and policy support for domestic innovation in China, India, Japan, South Korea, and Australia. Demand is strongest in orthopedic implants, dental biomaterials, cardiovascular devices, wound care, ophthalmology, and regenerative medicine, with aging demographics in Japan and South Korea and rising chronic disease burdens in China and India reinforcing long-term clinical need.

North America remains a leading commercialization region due to established hospital infrastructure, high procedure volumes, strong biomedical research funding, FDA-recognized testing pathways, and deep university-clinician-manufacturer collaboration. The United States is particularly influential in advanced polymers, tissue scaffolds, drug-device combinations, resorbable materials, and 3D-printed implant platforms, while Canada adds strength in regenerative medicine, clinical research networks, and publicly supported health innovation.

Europe is defined by premium clinical standards, sustainability priorities, and rigorous evidence requirements under EU MDR. Germany, France, Italy, Spain, and the United Kingdom support strong adoption in dental, orthopedic, wound care, cardiovascular, and tissue engineering applications. Latin America is led by Brazil and Mexico, where rising private healthcare access, trauma care needs, dental procedures, and medical tourism support demand for cost-effective and clinically proven biomaterials. The Middle East is investing in specialty care, advanced hospitals, and surgical capacity, especially across GCC markets, while Africa presents long-term potential tied to healthcare access expansion, orthopedic trauma care, maternal health systems, and affordable wound management solutions.

Key Group Insights Across Global Biomaterials Markets

ASEAN markets are gaining relevance as medical tourism, hospital investment, and local device assembly expand across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The region is well positioned for dental products, wound dressings, surgical consumables, and cost-competitive polymer-based devices, although regulatory harmonization, product registration efficiency, and clinical validation remain important differentiators.

The GCC is prioritizing advanced healthcare capacity, specialty surgery, domestic life sciences investment, and medical technology localization, creating opportunities for premium orthopedic, dental, cardiovascular, and wound-care biomaterials. The European Union remains a benchmark market because EU MDR compliance often strengthens credibility in other jurisdictions, making clinical evidence, post-market surveillance, traceability, and risk management essential competitive assets.

BRICS countries represent large-volume clinical demand and manufacturing scale, led by China, India, and Brazil, with Russia and South Africa contributing needs in trauma care, orthopedics, and hospital modernization. G7 markets lead in high-value innovation, reimbursement sophistication, biocompatibility science, and clinical adoption of next-generation biomaterials. NATO-linked procurement priorities can also influence trauma care, surgical readiness, infection control, burn treatment, and resilient medical supply chains, particularly for materials used in emergency and defense-related healthcare settings.

Key Country Insights for Biomaterials

The United States leads in biomaterials innovation through strong medtech ecosystems, federally funded biomedical research, FDA engagement, and commercialization in orthopedic, cardiovascular, wound care, dental, ophthalmic, and drug delivery applications. Canada benefits from regenerative medicine research, biomaterials science, and hospital-based innovation, while Mexico is strengthening its role in medical device manufacturing, nearshoring, and cross-border supply chain integration.

Brazil is the most influential Latin American biomaterials market, supported by orthopedic, dental, trauma, and hospital demand, while Mexico continues to benefit from private healthcare expansion and device production capabilities. The United Kingdom has deep strengths in university-led materials science, translational research, and advanced therapy development. Germany remains a European anchor for precision engineering, implantable devices, and dental biomaterials, while France supports strong clinical research, healthcare infrastructure, and implantable device expertise. Italy and Spain contribute established dental, orthopedic, and biomedical manufacturing capabilities, while Russia maintains demand in trauma, orthopedics, and domestic substitution strategies.

China is scaling domestic biomaterials production and high-volume clinical adoption, supported by hospital expansion, orthopedic demand, and policy emphasis on medical technology self-sufficiency. India is driven by affordability, expanding hospitals, dental care growth, and a large chronic disease burden, including diabetes-related wound care needs. Japan is a leader in high-quality ceramics, aging-related implant demand, and regenerative medicine regulation. Australia supports advanced clinical research, trauma care, and specialty adoption, while South Korea combines electronics, precision manufacturing, dental expertise, aesthetic procedures, and strong hospital technology adoption to strengthen its biomaterials position.

Actionable Recommendations for Biomaterials Leaders

Industry leaders should prioritize biomaterial platforms that address clear clinical burdens, including musculoskeletal disease, diabetes-related wounds, cardiovascular disease, dental restoration, ophthalmic disorders, and age-related tissue degeneration. Portfolio decisions should be anchored in measurable outcomes such as reduced infection, faster healing, improved osseointegration, longer implant life, reduced inflammation, and fewer revision procedures.

Companies should integrate biocompatibility, sterilization, manufacturability, and regulatory strategy from the earliest design stage. Building ISO 10993-aligned testing plans, chemical characterization workflows, risk management files, usability evidence, and post-market evidence systems can reduce approval risk and strengthen payer and clinician confidence.

Leaders should also invest in AI-enabled materials discovery, additive manufacturing validation, supplier diversification, lifecycle sustainability, and robust quality systems. Strategic partnerships with hospitals, universities, contract research organizations, testing laboratories, and specialty manufacturers can accelerate clinical validation, improve product performance, and support faster market access.

Research Methodology

This executive summary is developed using a structured secondary research approach aligned with market intelligence best practices. Inputs include public health datasets, regulatory guidance, peer-reviewed literature, medical device standards, clinical adoption trends, manufacturing indicators, and macroeconomic factors relevant to biomaterials demand.

Key sources considered include the World Health Organization, International Diabetes Federation, United Nations population data, U.S. FDA guidance, European Commission medical device regulations, ISO standards, OECD health indicators, national healthcare statistics, and published scientific research on biomaterials performance, biocompatibility, degradation behavior, and clinical use.

The analysis triangulates clinical need, regulatory direction, material innovation, manufacturing capacity, supply chain resilience, and regional healthcare investment. Qualitative insights are validated against observable market drivers and documented healthcare indicators rather than unsupported projections, supporting an evidence-based view of biomaterials opportunities.

Conclusion

Biomaterials are moving from passive structural components to intelligent, bioactive, and application-specific platforms that support better patient outcomes. Demand is reinforced by aging demographics, chronic disease prevalence, surgical innovation, trauma care needs, and the requirement for safer, longer-lasting medical technologies.

The most competitive organizations will combine scientific rigor with scalable manufacturing, regulatory readiness, and clinical evidence generation. AI, additive manufacturing, surface engineering, antimicrobial technologies, bioresorbable materials, and regenerative medicine will continue to reshape how biomaterials are discovered, tested, and commercialized.

Regional growth patterns will differ by healthcare infrastructure, reimbursement maturity, regulatory readiness, and manufacturing capacity, but the global direction is clear: validated, high-performance biomaterials will remain essential to the future of medical devices, implants, wound care, drug delivery, and tissue repair.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Biomaterials Market, by Type

  • 7.1. Ceramics
    • 7.1.1. Alumina
    • 7.1.2. Bioglass
    • 7.1.3. Hydroxyapatite
    • 7.1.4. Zirconia
  • 7.2. Metallic
  • 7.3. Synthetic Polymers
    • 7.3.1. Polycaprolactone (PCL)
    • 7.3.2. Polyglycolic acid (PGA)
    • 7.3.3. Polylactic acid (PLA)
    • 7.3.4. Polylactic-co-glycolic acid (PLGA)
    • 7.3.5. Polyethylene (PE)
    • 7.3.6. Polypropylene (PP)
    • 7.3.7. Polyurethane (PU)
    • 7.3.8. Polyvinyl alcohol (PVA)

8. Biomaterials Market, by Product Form

  • 8.1. Powders & Granules
  • 8.2. Fibers & Meshes
  • 8.3. Films
  • 8.4. Foams
  • 8.5. Coatings

9. Biomaterials Market, by Application

  • 9.1. Cardiovascular
    • 9.1.1. Guidewires
    • 9.1.2. Implantable Cardiac Defibrillators
    • 9.1.3. Pacemakers
    • 9.1.4. Sensors
    • 9.1.5. Stents
    • 9.1.6. Vascular Grafts
  • 9.2. Dental
    • 9.2.1. Bone Grafts & Substitutes
    • 9.2.2. Dental Implants
    • 9.2.3. Dental Membranes
    • 9.2.4. Tissue Regeneration Materials
  • 9.3. Ophthalmology
  • 9.4. Orthopedic
    • 9.4.1. Bioresorbable Tissue Fixation Products
    • 9.4.2. Joint Replacement biomaterials
    • 9.4.3. Orthobiologics
    • 9.4.4. Spine Biomaterials
    • 9.4.5. Viscosupplementation
  • 9.5. Urinary
  • 9.6. Wound Healing
    • 9.6.1. Adhesion Barrier
    • 9.6.2. Fracture Healing Device
    • 9.6.3. Internal Tissue Sealant
    • 9.6.4. Skin Substitutes
    • 9.6.5. Surgical Hemostats

10. Biomaterials Market, by End User

  • 10.1. Biotechnology Companies
  • 10.2. Hospitals
  • 10.3. Research Laboratories
  • 10.4. Specialty Clinics

11. Biomaterials Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Biomaterials Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Biomaterials Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Aroa Biosurgery Limited
  • 15.2. BASF SE
  • 15.3. Berkeley Advanced Biomaterials Inc.
  • 15.4. Bezwada Biomedical, LLC
  • 15.5. Carpenter Technology Corporation
  • 15.6. Celanese Corporation
  • 15.7. CoorsTek, Inc.
  • 15.8. Corbion N.V.
  • 15.9. Covestro AG
  • 15.10. Dentsply Sirona Inc.
  • 15.11. DSM-Firmenich AG
  • 15.12. Evonik Industries AG
  • 15.13. Exactech, Inc.
  • 15.14. Heraeus Holding GmbH
  • 15.15. Integra LifeSciences Corporation
  • 15.16. Invibio Limited
  • 15.17. Modern Meadow, Inc.
  • 15.18. MycoWorks, Inc.
  • 15.19. Noble Biomaterials, Inc.
  • 15.20. Stryker Corporation
  • 15.21. TissueForm, Inc.
  • 15.22. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOMATERIALS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIOMATERIALS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIOMATERIALS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIOMATERIALS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CERAMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CERAMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CERAMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ALUMINA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALUMINA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ALUMINA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOGLASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOGLASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOGLASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HYDROXYAPATITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HYDROXYAPATITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HYDROXYAPATITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ZIRCONIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ZIRCONIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ZIRCONIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL METALLIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL METALLIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL METALLIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SYNTHETIC POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SYNTHETIC POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SYNTHETIC POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POLYCAPROLACTONE (PCL) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POLYCAPROLACTONE (PCL) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POLYCAPROLACTONE (PCL) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POLYGLYCOLIC ACID (PGA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYGLYCOLIC ACID (PGA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYGLYCOLIC ACID (PGA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYLACTIC ACID (PLA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POLYLACTIC ACID (PLA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POLYLACTIC ACID (PLA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POLYLACTIC-CO-GLYCOLIC ACID (PLGA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POLYLACTIC-CO-GLYCOLIC ACID (PLGA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POLYLACTIC-CO-GLYCOLIC ACID (PLGA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POLYURETHANE (PU) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POLYURETHANE (PU) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POLYURETHANE (PU) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POLYVINYL ALCOHOL (PVA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POLYVINYL ALCOHOL (PVA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POLYVINYL ALCOHOL (PVA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POWDERS & GRANULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POWDERS & GRANULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POWDERS & GRANULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FIBERS & MESHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FIBERS & MESHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FIBERS & MESHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FILMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FILMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FILMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FOAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FOAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FOAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GUIDEWIRES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GUIDEWIRES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GUIDEWIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMPLANTABLE CARDIAC DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IMPLANTABLE CARDIAC DEFIBRILLATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMPLANTABLE CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DENTAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DENTAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DENTAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DENTAL MEMBRANES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DENTAL MEMBRANES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DENTAL MEMBRANES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TISSUE REGENERATION MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TISSUE REGENERATION MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TISSUE REGENERATION MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ORTHOPEDIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ORTHOPEDIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ORTHOPEDIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIORESORBABLE TISSUE FIXATION PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIORESORBABLE TISSUE FIXATION PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIORESORBABLE TISSUE FIXATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SPINE BIOMATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SPINE BIOMATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SPINE BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL URINARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL URINARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL URINARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL WOUND HEALING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL WOUND HEALING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL WOUND HEALING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ADHESION BARRIER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ADHESION BARRIER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL FRACTURE HEALING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL FRACTURE HEALING DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL FRACTURE HEALING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL INTERNAL TISSUE SEALANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTERNAL TISSUE SEALANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL INTERNAL TISSUE SEALANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL HEMOSTATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. GCC BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. GCC BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 238. GCC BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 239. GCC BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 240. GCC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. GCC BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 242. GCC BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 243. GCC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 244. GCC BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 245. GCC BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. G7 BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. G7 BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. G7 BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 271. G7 BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 272. G7 BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 273. G7 BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. G7 BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 275. G7 BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 276. G7 BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 277. G7 BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 278. G7 BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. NATO BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. NATO BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. NATO BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 282. NATO BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 283. NATO BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 284. NATO BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. NATO BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 286. NATO BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 287. NATO BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 288. NATO BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 289. NATO BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 305. CANADA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 306. CANADA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 307. CANADA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. CANADA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 309. CANADA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 310. CANADA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 311. CANADA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 312. CANADA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. MEXICO BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. MEXICO BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. MEXICO BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 316. MEXICO BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 317. MEXICO BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 318. MEXICO BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. MEXICO BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 320. MEXICO BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 321. MEXICO BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 322. MEXICO BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 323. MEXICO BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. BRAZIL BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. BRAZIL BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. BRAZIL BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 327. BRAZIL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 328. BRAZIL BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 329. BRAZIL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 330. BRAZIL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 331. BRAZIL BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 332. BRAZIL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 333. BRAZIL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 334. BRAZIL BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED KINGDOM BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 346. GERMANY BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 347. GERMANY BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. GERMANY BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 349. GERMANY BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 350. GERMANY BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 351. GERMANY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 352. GERMANY BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 353. GERMANY BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 354. GERMANY BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 355. GERMANY BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 356. GERMANY BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 357. FRANCE BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 358. FRANCE BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 359. FRANCE BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 360. FRANCE BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 361. FRANCE BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 362. FRANCE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 363. FRANCE BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 364. FRANCE BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 365. FRANCE BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 366. FRANCE BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 367. FRANCE BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 368. RUSSIA BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 369. RUSSIA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 370. RUSSIA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 371. RUSSIA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 372. RUSSIA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 373. RUSSIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 374. RUSSIA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 375. RUSSIA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 376. RUSSIA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 377. RUSSIA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 378. RUSSIA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 379. ITALY BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 380. ITALY BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 381. ITALY BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 382. ITALY BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 383. ITALY BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 384. ITALY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 385. ITALY BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 386. ITALY BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 387. ITALY BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 388. ITALY BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 389. ITALY BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 390. SPAIN BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 391. SPAIN BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 392. SPAIN BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 393. SPAIN BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 394. SPAIN BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)

TABLE